# Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial

> **NCT05367206** · PHASE3 · RECRUITING · sponsor: **Sun Yat-sen University** · enrollment: 280 (estimated)

## Conditions studied

- Cervical Cancer
- Neoadjuvant Chemotherapy
- Bulky Neoplasm

## Interventions

- **DRUG:** Albumin-Bound Paclitaxel
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT05367206
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-14
- **Primary completion:** 2024-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05367206

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05367206, "Neoadjuvant Chemotherapy Followed by Chemoradiation Versus Chemoradiation for Stage IIIC Cervical Cancer Patients: A Randomized Phase III Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05367206. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*